Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.31.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ED.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BU.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.576NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.325NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.521NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.378NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.206NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EF.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.8.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.54.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.30.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
MN.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.63NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LE.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used